Anna Tenstam-Lundvall
Corporate Officer/Principal bei ColBar LifeScience Ltd.
Profil
Anna Tenstam-Lundvall is Executive Vice President of Commercialization for ColBar LifeScience Ltd.
Prior to joining ColBar, she was Vice President and Global Business Unit Director of Q-Med AB.
She held various positions at Bristol-Myers Squibb.
Lederle, Cyanamid and Pharmacia.
Ms. Tenstam-Lundvall received a B.Sc.
degree in Biomedical engineering from Uppsala University.
Aktive Positionen von Anna Tenstam-Lundvall
| Unternehmen | Position | Beginn |
|---|---|---|
ColBar LifeScience Ltd.
 ColBar LifeScience Ltd. Medical SpecialtiesHealth Technology ColBar LifeSciences Ltd. develops technology for tissue regeneration and tissue engineering. It manufactures and commercializes bio surgical products for applications in reconstructive medicine and tissue engineering. Its main focus is on the repair of damaged tissue in the human body like soft tissue, bone and skin. The company was founded in 1995 and is headquartered in Herzliya, Israel. | Corporate Officer/Principal | - |
Ausbildung von Anna Tenstam-Lundvall
| University of Uppsala | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 1 |
|---|---|
ColBar LifeScience Ltd.
ColBar LifeScience Ltd. Medical SpecialtiesHealth Technology ColBar LifeSciences Ltd. develops technology for tissue regeneration and tissue engineering. It manufactures and commercializes bio surgical products for applications in reconstructive medicine and tissue engineering. Its main focus is on the repair of damaged tissue in the human body like soft tissue, bone and skin. The company was founded in 1995 and is headquartered in Herzliya, Israel. | Health Technology |
